# US Small Animal Imaging Market > US Small Animal Imaging Market Research Report By Product (Optical Imaging, Nuclear Imaging, Reagent) and By Application (Monitoring Drug Treatment Programme, Bio Distribution Studies, Cancer Cell Detection, Biomarkers, Longitudinal Studies) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 6.87% - **2024:** $ 311.59 Million - **2025:** $ 332.99 Million - **2035:** $ 647.26 Million - **Key Players:** Bruker Corporation (US), PerkinElmer Inc. (US), Fujifilm Holdings Corporation (JP), Siemens Healthineers (DE), GE Healthcare (US), Canon Medical Systems Corporation (JP), Agfa-Gevaert Group (BE), Mediso Medical Imaging Systems (HU) **Report ID:** MRFR/MED/17452-HCR · **Pages:** 100 · **Author:** Nidhi Mandole & Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-small-animal-imaging-market-18998 --- ## Market Summary ## **US Small Animal Imaging Market Overview** As per MRFR analysis, the US Small Animal Imaging Market Size was estimated at 249.56 (USD Million) in 2023. The US Small Animal Imaging Market Industry is expected to grow from 266.7 (USD Million) in 2024 to 554.34 (USD Million) by 2035. The US Small Animal Imaging Market CAGR (growth rate) is expected to be around 6.878% during the forecast period (2025 - 2035). ### **Key Market Trends Highlighted** The US Small Animal Imaging Market is influenced by several key market drivers that are shaping its growth trajectory. One significant driver is the increasing focus on preclinical research and development in the pharmaceutical and biotechnology industries. This is largely because small animal imaging technologies facilitate the assessment of the safety and efficacy of new drugs before they proceed to human trials, which aligns with the US government's emphasis on advancing biomedical innovations. Moreover, the rise in chronic diseases among pets and the growing demand for pet healthcare services have heightened the need for effective imaging techniques in veterinary practices. Opportunities abound in the realm of technological advancements, such as the integration of artificial intelligence and machine learning into small animal imaging systems. These innovations can enhance image quality and analysis, leading to better diagnosis and treatment options. Additionally, the emergence of hybrid imaging modalities is another area ripe for exploration, as these systems can deliver comprehensive insights and reduce the time needed for diagnostics in clinical settings. Recent trends in the US highlight a growing adoption of non-invasive imaging techniques which are favored for their safety and efficacy. Researchers are increasingly utilizing modalities such as MRI, PET, and CT to capture detailed images that are crucial for studies involving various small animal models. Furthermore, collaborations among academic institutions, research organizations, and the veterinary community are on the rise, which fosters the development of more sophisticated imaging solutions tailored to specific research needs. The overall trend points towards a more integrated approach that combines advanced imaging technologies with enhanced research methodologies to boost the capabilities of the US Small Animal Imaging Market. Source: Primary Research, Secondary Research, MRFR Database and Analyst Review ## **US Small Animal Imaging Market Drivers** ### **Increased Investment in Research and Development** The US Small Animal Imaging Market Industry is witnessing significant growth driven by increased investment in Research and Development activities. According to the National Institutes of Health (NIH), funding for biomedical research in the United States has seen a steady increase, with an allocation of over 42 billion USD in 2022 alone. This surge supports advancements in imaging technologies and methodologies, enabling more precise animal studies and experimental models. Organizations like the American Association for Laboratory Animal Science (AALAS) promote innovative approaches, which are crucial for developing new imaging solutions. As more biotechnology and pharmaceutical companies invest in small animal imaging for drug discovery and safety evaluations, the need for advanced imaging techniques escalates, effectively propelling the US [Small Animal Imaging Market](../../../reports/small-animal-imaging-market-6175) forward. The growing focus on preclinical studies to expedite clinical trials further emphasizes this trend, as small animal models are essential for validating new therapies and treatment methods. ### **Rising Incidence of Chronic Diseases** The growing prevalence of chronic diseases in the United States, such as cancer and cardiovascular diseases, is a vital driver for the US Small Animal Imaging Market Industry. According to data from the Centers for Disease Control and Prevention (CDC), nearly 6 out of 10 adults in the US live with at least one chronic disease. This increases the demand for innovative imaging technologies that can facilitate the study of disease mechanisms and therapeutic responses in small animal models. Research entities like the American Cancer Society are emphasizing the importance of preclinical research in understanding the complexities of cancer, thereby increasing reliance on small animal imaging techniques. This heightened demand for accurate disease modeling and monitoring directly contributes to a flourishing market for small animal imaging solutions. ### **Technological Advancements in Imaging Techniques** Technological advancements in imaging techniques are crucial for the growth of the US Small Animal Imaging Market Industry. Innovations such as 3D imaging, molecular imaging, and hybrid imaging modalities have become increasingly sophisticated and accessible. The US Food and Drug Administration (FDA) continues to approve new imaging agents and devices, which streamline research processes and improve imaging resolution. Leading organizations like Siemens Healthineers and GE Healthcare are at the forefront of developing cutting-edge imaging systems, which enhance the quality and efficacy of small animal research. As more laboratories adopt these advanced techniques, the ability to perform intricate evaluations of physiological processes and disease progression increases, further driving market expansion. ### **Growing Focus on Personalized Medicine** The paradigm shift towards personalized medicine is significantly impacting the US Small Animal Imaging Market Industry. Increasing recognition of the need for individualized treatment approaches is propelling the use of small animal models to test specific therapies tailored to patients. The National Cancer Institute has reported that about 70% of cancer therapies entering clinical trials fail due to lack of efficacy, highlighting the importance of effective preclinical platforms to assess drug responses. Institutions engaged in genomic research are establishing strong ties with the preclinical imaging market, which allows for accurate prediction of treatment outcomes in diverse populations. This trajectory is expected to foster innovations in imaging technologies, as more researchers seek to validate personalized treatment strategies using small animal models. ## **US Small Animal Imaging Market Segment Insights** ### **Small Animal Imaging Market Product Insights** The US Small Animal Imaging Market, particularly within the Product segment, signifies a crucial area of development within the broader industry. This market is essential for various applications in research and clinical settings, driving advancements in the understanding of diseases and therapeutic efficacy. Among the different categories, Optical Imaging stands out for its non-invasive nature, enabling high-resolution imaging of anatomical structures and physiological processes. This technology aids researchers substantially in preclinical studies, enhancing the visualization of cellular and molecular activity in live small animals. Nuclear Imaging is similarly pivotal, offering insights into metabolic and physiological functions through techniques like positron emission tomography. This modality is particularly significant in the context of oncology, as it allows the assessment of tumor characteristics and treatment responses effectively. Meanwhile, Reagents play a key role across various imaging techniques, as they provide essential contrast and labeling capabilities crucial for accurate imaging. The demand for high-quality reagents is fueled by ongoing scientific research and development efforts aimed at improving imaging specificity and sensitivity. Collectively, these components of the US Small Animal Imaging Market's Product segment underline the importance of innovation and technological advancement, aligning with the growing emphasis on precision medicine and personalized therapies in the US healthcare landscape. The market statistics reflect the robust growth potential in this field, driven by factors such as increasing investment in Research and Development, rising government funding for biomedical research, and the growing prevalence of diseases requiring meticulous study through imaging modalities. As the industry continues to evolve, the integration of emerging technologies promises to further enhance the capabilities and applications of small animal imaging, paving the way for more effective therapeutic outcomes. Source: Primary Research, Secondary Research, MRFR Database and Analyst Review ### **Small Animal Imaging Market Application Insights** The US Small Animal Imaging Market Application segment encompasses various crucial aspects, contributing significantly to the growth and development of the market. Monitoring Drug Treatment Programmes has emerged as a vital application, facilitating real-time observations of treatment responses in small animal models, ultimately enhancing drug development processes. Bio Distribution Studies serve a key role by enabling researchers to investigate the distribution of therapeutic agents within biological systems, which helps inform dosage and delivery methods. Cancer Cell Detection is another area of importance, as it aids in early identification of tumor development, leading to improved treatment strategies and patient outcomes. The exploration of Biomarkers is instrumental in understanding disease mechanisms, helping researchers to correlate specific biological indicators with health conditions. Moreover, Longitudinal Studies provide invaluable insights into the progression of diseases over time, allowing for comprehensive analysis and informed therapeutic approaches. Together, these applications highlight the diverse utility of imaging technologies in advancing research and improving clinical outcomes across various fields in the US Small Animal Imaging Market, ultimately driving innovation and efficiency in health care advancements. ## **US Small Animal Imaging Market Key Players and Competitive Insights** The US Small Animal Imaging Market is a specialized sector that focuses on the development and use of advanced imaging techniques for small animals, which are crucial in both research and clinical diagnostics. This market has witnessed significant growth due to increasing investments in preclinical research, pharmaceutical development, and the growing demand for advanced imaging technologies among research institutions. The competitive landscape is characterized by a mix of established players and emerging companies, all vying to offer innovative solutions that enhance the accuracy and efficiency of small animal imaging. The dynamics of this market are influenced by factors such as technological advancements, regulatory requirements, and the rising prevalence of chronic diseases in small animal populations. Companies are leveraging partnerships, collaborations, and mergers and acquisitions to strengthen their market positions and expand their product offerings to meet the evolving needs of researchers and veterinarians. ### **Key Companies** ### **Company Profiles** #### **3dimensional Pharmaceuticals** 3dimensional Pharmaceuticals has carved a niche for itself in the US Small Animal Imaging Market through its innovative imaging solutions that focus on enhancing drug development and preclinical research capabilities. The company is known for its strength in providing high-resolution imaging technologies that allow researchers to visualize biological processes in real-time. This capability is crucial for advancing the understanding of disease progression and the effectiveness of new therapies. 3dimensional Pharmaceuticals has established a strong market presence by collaborating with academic institutions and pharmaceutical companies, making it a preferred choice for those in need of reliable imaging solutions. Their emphasis on integrating advanced imaging modalities with data analytics further solidifies their competitive edge, enabling researchers to gain deeper insights into their studies. #### **Radiology Partners** Radiology Partners has made significant strides in enhancing the US Small Animal Imaging Market by offering a broad range of imaging services geared towards veterinary applications. Their service portfolio includes advanced modalities such as MRI, CT scans, and ultrasound, which are critical for precise diagnostics in small animals. Radiology Partners stands out with its extensive network of board-certified radiologists who specialize in veterinary imaging, ensuring high-quality services for both client practices and animal healthcare facilities. The company is recognized for its commitment to innovation, utilizing the latest technologies to improve imaging accuracy and turnaround times. Strategic partnerships with veterinary clinics and hospitals have allowed Radiology Partners to expand its market presence significantly. Furthermore, the company’s proactive approach to mergers and acquisitions has enabled it to consolidate its position in the market, enhancing its capabilities and service offerings in the rapidly evolving landscape of small animal imaging. ## **US Small Animal Imaging Market Industry Developments** The US Small Animal Imaging Market has experienced significant developments recently, particularly with advancements in imaging technologies and their applications in research and preclinical studies. Companies such as Bruker and Thermo Fisher Scientific have unveiled new imaging systems that enhance resolution and depth of visualization, driving increased adoption among academic institutions and research laboratories. In August 2023, GE Healthcare announced a collaboration with several universities to accelerate the use of their imaging technologies in small animal research, underscoring the importance of partnerships in this industry. Mergers and acquisitions play a critical role, with notable activity reported; in March 2023, Philips moved to acquire a biotech firm specializing in advanced imaging techniques which could strengthen their position in the market. The market valuation has seen a robust growth trajectory, with a compound annual growth rate expected to reflect the expanding applications of these technologies in drug development and disease modeling. Cumulatively, the last two to three years have seen heightened investment in small animal imaging platforms, promoting innovation and enhancing the quality of preclinical findings. ## **US Small Animal Imaging Market Segmentation Insights** ### **Small Animal Imaging Market Product Outlook** ### **Small Animal Imaging Market Application Outlook** ## Market Drivers ### Growing Pet Insurance Adoption The increasing adoption of pet insurance in the US is contributing to the growth of the small animal-imaging market. As more pet owners secure insurance coverage, they are more likely to seek advanced diagnostic services, including imaging. This trend is reflected in the pet insurance market, which has seen a growth rate of approximately 15% annually over the past few years. With insurance coverage, pet owners are more inclined to pursue necessary imaging procedures, thereby driving demand within the small animal-imaging market. This shift not only benefits pet owners but also encourages veterinary practices to enhance their imaging capabilities. ### Increased Focus on Animal Welfare There is a growing emphasis on animal welfare within the veterinary community, which is positively impacting the small animal-imaging market. As veterinarians and pet owners prioritize the health and well-being of animals, the demand for comprehensive diagnostic tools is likely to increase. This focus on welfare is reflected in the rising number of veterinary schools and training programs in the US, which are incorporating advanced imaging techniques into their curricula. The small animal-imaging market stands to benefit from this trend, as more practitioners become skilled in utilizing imaging technologies to ensure better health outcomes for pets. ### Rising Demand for Veterinary Services The small animal-imaging market is experiencing a notable increase in demand for veterinary services, driven by a growing awareness of pet health and wellness. As pet owners become more informed about the benefits of advanced imaging techniques, such as MRI and CT scans, the need for these services is likely to rise. In the US, the veterinary services market was valued at approximately $30 billion in 2023, with imaging services representing a significant segment. This trend suggests that as more pet owners seek specialized care, the small animal-imaging market will expand, providing opportunities for veterinary practices to invest in advanced imaging technologies. ### Regulatory Support for Veterinary Imaging Regulatory support for veterinary imaging practices is emerging as a significant driver for the small animal-imaging market. The US government has been actively promoting the use of advanced imaging technologies in veterinary medicine through various initiatives and funding programs. This support not only encourages the adoption of new technologies but also ensures that veterinary practices comply with safety and quality standards. As regulations evolve to accommodate advancements in imaging, the small animal-imaging market is likely to see increased investment and innovation, ultimately enhancing the quality of care provided to small animals. ### Integration of Advanced Imaging Technologies The integration of advanced imaging technologies into veterinary practices is a key driver for the small animal-imaging market. Innovations such as digital radiography and ultrasound are becoming increasingly accessible to veterinary clinics, enhancing diagnostic capabilities. The market for veterinary imaging equipment is projected to grow at a CAGR of around 8% from 2023 to 2028, indicating a robust demand for these technologies. This growth is likely to be fueled by the need for accurate and timely diagnoses, which are essential for effective treatment plans in small animals. Consequently, the small animal-imaging market is poised for significant advancements as technology continues to evolve. ## Future Outlook The [Small Animal Imaging Market](https://www.marketresearchfuture.com/reports/small-animal-imaging-market-6175) is projected to grow at a 6.87% CAGR from 2025 to 2035, driven by technological advancements and increasing demand for veterinary diagnostics. **New opportunities:** - Development of portable imaging devices for veterinary practices - Integration of AI for enhanced diagnostic accuracy - Expansion of telemedicine services for remote imaging consultations By 2035, the market is expected to achieve substantial growth and innovation. ## Segment Insights ### By Product: Imaging Modality (Largest) vs. Reagent (Fastest-Growing) In the US small animal-imaging market, imaging modality currently holds the largest market share, driven by advancements in technology and increasing demand for accurate diagnostics in veterinary practices. It encompasses a range of techniques such as MRI, CT scans, and ultrasound, which are essential for comprehensive pet care. In contrast, the reagent segment is emerging rapidly as diagnostic tools improve, highlighting a shift towards more targeted therapies and personalized pet healthcare solutions. The growth in the imaging modality segment is propelled by an increasing pet ownership trend, coupled with a heightened focus on pet health and wellness. Moreover, the development of more sophisticated imaging equipment is enhancing diagnostic capabilities, leading to a significant uptick in usage among veterinary professionals. Conversely, the reagent segment is characterized by innovative diagnostic protocols and new product introductions that align with the veterinary community's evolving needs, thus ensuring this segment remains the fastest-growing area of the market. Imaging Modality: MRI (Dominant) vs. Reagent: Novel Antibodies (Emerging) In the US small animal-imaging market, MRI represents the dominant imaging modality, favored for its non-invasive nature and ability to provide detailed internal views of pets without the need for exploratory surgery. This modality has become the standard for diagnosing soft tissue injuries and conditions prevalent in small animals. On the other hand, novel antibodies in the reagent segment are emerging as crucial tools for disease detection and treatment monitoring, supporting the growing trend towards specific and personalized veterinary care. Their development is spurred by research advancements and increasing awareness of animal health, positioning novel antibodies as an essential component of the future veterinary landscape. ### By Imaging Modality: Optical Imaging (Largest) vs. Nuclear Imaging (Fastest-Growing) In the current landscape, Optical Imaging holds a significant share of the US small animal-imaging market, showcasing its prominence through advanced technologies that allow real-time imaging with high resolution. This segment is extensively utilized in various preclinical studies due to its non-invasive nature, making it a popular choice among researchers and veterinarians. On the other hand, Nuclear Imaging is identifying itself as the fastest-growing segment within this market. The increasing inclination towards advanced diagnostic procedures and the rise in demand for precision medicine are pivotal drivers behind its growth. Innovations in imaging tracers and improvements in detection technology further fuel this trend, solidifying Nuclear Imaging's potential in the competitive market. Imaging Modality: Optical Imaging (Dominant) vs. Nuclear Imaging (Emerging) Optical Imaging stands out as the dominant modality in the US small animal-imaging market, renowned for its ability to provide high-resolution images using light detection without the need for ionizing radiation. This technique is particularly favored for its speed and affordability, allowing researchers to conduct rapid imaging procedures on small animals. Conversely, Nuclear Imaging is emerging rapidly, driven by advancements in radioisotope development and enhanced imaging techniques. This segment is particularly effective in functional imaging, making it invaluable for understanding various biological processes in small animals. As precision medicine continues to gain traction, the demand for both modalities is expected to grow, with Optical Imaging leading in usage while Nuclear Imaging captures a growing share of innovative applications. ### By Application: Monitoring Drug Treatment Programme (Largest) vs. Cancer Cell Detection (Fastest-Growing) In the US small animal-imaging market, the Monitoring Drug Treatment Programme holds the largest share, primarily due to its essential role in evaluating the efficacy of therapies in small animals. Bio Distribution Studies and Biomarkers also occupy considerable segments but do not match the dominance of the Monitoring Drug Treatment Programme. Conversely, Cancer Cell Detection is emerging rapidly, driven by increasing interest in veterinary oncology and advancements in imaging techniques. The overall growth trends within this segment are propelled by increased pet healthcare expenditure and a growing trend towards precision veterinary medicine. The rise in chronic diseases among small animals also drives demand for innovative imaging solutions like Cancer Cell Detection, making it the fastest-growing application. The expanding focus on early disease detection further influences these growth dynamics, as pet owners increasingly seek effective monitoring tools for their pets' health. Monitoring Drug Treatment Programme (Dominant) vs. Cancer Cell Detection (Emerging) The Monitoring Drug Treatment Programme is a dominant segment in the US small animal-imaging market, as it serves a critical function in tracking the response of small animals to prescribed therapies. Characterized by a strong foundation in clinical practices, this application is crucial for veterinary professionals to optimize treatment protocols and improve patient outcomes. On the other hand, Cancer Cell Detection is becoming an emerging application within this market, fueled by advancements in imaging technologies and an increasing prevalence of cancer in small animals. This application focuses on identifying cancerous cells at early stages, thus enhancing treatment efficacy and improving the overall survival rates of affected animals. Together, these segments reflect the dynamic interplay of necessity and innovation in veterinary healthcare. ## Competitive Benchmarking The small animal-imaging market is characterized by a dynamic competitive landscape, driven by advancements in technology and increasing demand for precise imaging solutions in research and veterinary applications. Key players such as Bruker Corporation (US), PerkinElmer Inc. (US), and GE Healthcare (US) are at the forefront, each adopting distinct strategies to enhance their market presence. Bruker Corporation (US) focuses on innovation, particularly in developing high-resolution imaging systems that cater to the needs of academic and pharmaceutical research. Meanwhile, PerkinElmer Inc. (US) emphasizes partnerships with research institutions to expand its product offerings and improve customer engagement. GE Healthcare (US) is leveraging digital transformation initiatives to streamline operations and enhance the user experience, thereby positioning itself as a leader in the market.The business tactics employed by these companies reflect a moderately fragmented market structure, where localized manufacturing and supply chain optimization are pivotal. Companies are increasingly localizing their production to reduce lead times and enhance responsiveness to market demands. This strategy not only improves operational efficiency but also allows for better alignment with regional regulatory requirements. The collective influence of these key players shapes a competitive environment that is both challenging and ripe for innovation, as companies strive to differentiate themselves through advanced technology and customer-centric solutions. In October Bruker Corporation (US) announced the launch of a new imaging system designed specifically for small animal research, which integrates advanced AI algorithms to enhance image clarity and analysis. This strategic move is likely to solidify Bruker’s position as a leader in the small animal-imaging sector, as it addresses the growing demand for high-quality imaging solutions that facilitate more accurate research outcomes. The incorporation of AI not only improves the functionality of the imaging systems but also aligns with broader trends in digitalization within the healthcare sector. In September PerkinElmer Inc. (US) entered into a strategic partnership with a leading veterinary research institution to co-develop imaging technologies tailored for small animal applications. This collaboration is expected to enhance PerkinElmer’s product portfolio and foster innovation through shared expertise. By aligning with academic institutions, PerkinElmer is likely to accelerate the development of cutting-edge imaging solutions that meet the evolving needs of researchers and veterinarians alike. In August GE Healthcare (US) unveiled a new cloud-based platform that integrates imaging data with advanced analytics tools, aimed at improving the efficiency of small animal imaging workflows. This initiative reflects GE’s commitment to digital transformation and positions the company to capitalize on the growing trend of data-driven decision-making in research environments. By providing researchers with enhanced analytical capabilities, GE Healthcare is likely to strengthen its competitive edge in the market. As of November the competitive trends in the small animal-imaging market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation and expanding their market reach. Looking ahead, it appears that competitive differentiation will evolve from traditional price-based competition to a focus on technological advancements, innovative solutions, and reliable supply chains. This shift suggests that companies that prioritize R&D and strategic partnerships will be better positioned to thrive in an increasingly competitive landscape. ## Recent News & Developments The US Small Animal Imaging Market has experienced significant developments recently, particularly with advancements in imaging technologies and their applications in research and preclinical studies. Companies such as Bruker and Thermo Fisher Scientific have unveiled new imaging systems that enhance resolution and depth of visualization, driving increased adoption among academic institutions and research laboratories. In August 2023, GE Healthcare announced a collaboration with several universities to accelerate the use of their imaging technologies in small animal research, underscoring the importance of partnerships in this industry. Mergers and acquisitions play a critical role, with notable activity reported; in March 2023, Philips moved to acquire a biotech firm specializing in advanced imaging techniques which could strengthen their position in the market. The market valuation has seen a robust growth trajectory, with a compound annual growth rate expected to reflect the expanding applications of these technologies in drug development and disease modeling. Cumulatively, the last two to three years have seen heightened investment in small animal imaging platforms, promoting innovation and enhancing the quality of preclinical findings. ## Report Scope | MARKET SIZE 2024 | 311.59(USD Million) | | --- | --- | | MARKET SIZE 2025 | 332.99(USD Million) | | MARKET SIZE 2035 | 647.26(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.87% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Bruker Corporation (US), PerkinElmer Inc. (US), Fujifilm Holdings Corporation (JP), Siemens Healthineers (DE), GE Healthcare (US), Canon Medical Systems Corporation (JP), Agfa-Gevaert Group (BE), Mediso Medical Imaging Systems (HU) | | Segments Covered | Product, Imaging Modality, Application | | Key Market Opportunities | Advancements in imaging technology enhance diagnostic capabilities in the small animal-imaging market. | | Key Market Dynamics | Technological advancements drive innovation in small animal-imaging, enhancing diagnostic capabilities and research applications. | | Countries Covered | US | ## Frequently Asked Questions **Q: What was the market valuation of the US small animal-imaging market in 2024?** A: The market valuation was $311.59 Million in 2024. **Q: What is the projected market valuation for the US small animal-imaging market by 2035?** A: The projected valuation for 2035 is $647.26 Million. **Q: What is the expected CAGR for the US small animal-imaging market during the forecast period 2025 - 2035?** A: The expected CAGR is 6.87% during the forecast period 2025 - 2035. **Q: Which imaging modalities are expected to show significant growth in the US small animal-imaging market?** A: Optical Imaging and Nuclear Imaging are expected to show significant growth, with valuations of $100.0 Million to $200.0 Million and $211.59 Million to $447.26 Million, respectively. **Q: What are the key applications driving the US small animal-imaging market?** A: Key applications include Cancer Cell Detection, Bio Distribution Studies, and Longitudinal Studies, with valuations ranging from $40.0 Million to $207.26 Million. **Q: Who are the leading players in the US small animal-imaging market?** A: Key players include Bruker Corporation, PerkinElmer Inc., and GE Healthcare, among others. **Q: What was the valuation of reagents in the US small animal-imaging market in 2024?** A: The valuation of reagents was $111.59 Million in 2024, projected to grow to $227.26 Million by 2035. **Q: How does the market for monitoring drug treatment programs compare to other applications?** A: The market for monitoring drug treatment programs was valued at $50.0 Million in 2024, with potential growth to $100.0 Million by 2035. **Q: What is the significance of biomarkers in the US small animal-imaging market?** A: Biomarkers are projected to grow from $40.0 Million to $80.0 Million, indicating their increasing relevance in research. **Q: What trends are anticipated in the US small animal-imaging market by 2035?** A: Trends suggest a continued increase in market valuation, driven by advancements in imaging technologies and applications. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-small-animal-imaging-market-18998*